Toon Digneffe is Head of Public Affairs and Partnerships Europe & Canada at Takeda. He has over 20 years’ experience in government affairs, communications, market access and patient advocacy at local, regional and global level. Mr Digneffe has extensive experience in pharmaceutical industry, as he has been working in the sector since 2002 after having spent time in the European Commission and Consultancy (Fleishman-Hillard) at the early start of his career. He worked as Head of Public Affairs for Shire since 2016, before its acquisition from Takeda. Previously, he worked for Baxter International for over 13 years, and for Baxalta, with roles of increasing responsibility at local, regional and global level. Since 2018, Toon serves as Executive Board member of the European Industry Association EUCOPE. Toon holds a Master in Political Science from the University of Leuven, Belgium/ University of Leicester, England and a Post-Graduate Degree in European Studies from the College of Europe, Bruges, Belgium. He is co-author of the book by Martin Westlake, “the Council of the European Union”, John Harper publishing.
-The global impact of U.S. changes – what opportunities could this mean for Europe and how can we make this an advantage for Europe?
-How will the pharmaceutical legislation and EU level changes affect rare disease investment, regulation, affordability and accessibility to patients?
-How can we ensure Europe’s R&D remains competitive, well-funded and sustainable?
-How should industry respond in order to keep innovating more therapies and to expedite the approval of new medicines?
-How can each multi-stakeholder contribute to a more sustainable ecosystem?